Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Severe Acute Respiratory Syndrome Coronavirus 2
View Full LandscapeTarget Indication
Severe Acute Respiratory Syndrome Coronavirus 2
Clinical Trial
NCT04625985Last updated: 1/23/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Allergic Rhinoconjunctivitis
Osteoarthritis of Knee
Alopecia
Influenza, Human
Arterial Hypertension